Department of Bariatric & Upper GI Surgery, Luton & Dunstable Hospital, Bedfordshire Hospitals NHS Foundation Trust, Lewsey Road, Luton, LU4 0DZ, UK.
Obes Surg. 2024 Mar;34(3):967-975. doi: 10.1007/s11695-023-07022-2. Epub 2024 Jan 19.
The aim of this meta-analysis was to compare the effects of LRYGB and LSG on dyslipidemia. Studies comparing the effects of LRYGB and LSG on dyslipidemia with follow-up of 12 months or more were included. Twenty-four studies comprising seven RCTs and 17 comparative observational studies were included. Meta-analysis of RCTs (n=487) showed that improvement/resolution of dyslipidemia was better after LRYGB (68.5%, n=161/235) compared to LSG (48.4%, n=122/252). Patients undergoing LRYGB were more than twice as likely to experience improvement/resolution in dyslipidemia compared to those undergoing LSG (OR 2.28, 95% CI 1.21-4.29, p=0.010). Both LRGYB and LSG appears effective in improving dyslipidemia at >12 months after surgery; however, this improvement is more than twice higher after LRYGB compared to LSG.
本荟萃分析的目的是比较 LRYGB 和 LSG 对血脂异常的影响。纳入了比较 LRYGB 和 LSG 对血脂异常影响且随访时间≥12 个月的研究。共纳入 24 项研究,包括 7 项 RCT 和 17 项观察性比较研究。RCT 的荟萃分析(n=487)显示,LRYGB(68.5%,n=161/235)后血脂异常的改善/缓解优于 LSG(48.4%,n=122/252)。与 LSG 相比,接受 LRYGB 的患者血脂异常改善/缓解的可能性是其两倍多(OR 2.28,95% CI 1.21-4.29,p=0.010)。LRGYB 和 LSG 在术后>12 个月时均能有效改善血脂异常;然而,与 LSG 相比,LRYGB 后的改善程度高出两倍多。